Growth Metrics

Merck (MRK) Revenue (2009 - 2026)

Merck (MRK) reported Revenue of $16.3 billion for Q1 2026, up 4.87% year-over-year from $15.5 billion in Q1 2025, and down 0.7% on a QoQ basis from $16.4 billion in Q4 2025.

Merck (MRK) has 18 years of Revenue data on file, last reported at $16.3 billion in Q1 2026.

  • Quarterly Revenue rose 4.87% year-over-year to $16.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.8 billion (up 2.89% YoY) and the FY2025 annual result came in at $65.0 billion, up 1.31% from the prior year.
  • Revenue declined to $16.3 billion in Q1 2026 per MRK's latest filing, from $16.4 billion in the prior quarter.
  • Across five years, Revenue topped out at $17.3 billion in Q3 2025 and bottomed at $13.8 billion in Q4 2022.
  • The 5-year median for Revenue is $15.8 billion (2024), against an average of $15.6 billion.
  • The widest annual swing landed in 2022, when Revenue surged 49.63%; it then decreased 8.89% in 2023.
  • Tracing MRK's Revenue over 5 years: stood at $13.8 billion in 2022, then increased by 5.78% to $14.6 billion in 2023, then gained by 6.79% to $15.6 billion in 2024, then advanced by 4.97% to $16.4 billion in 2025, then slipped by 0.7% to $16.3 billion in 2026.
  • Per Business Quant, the three latest MRK Revenue figures stand at $16.3 billion (Q1 2026), $16.4 billion (Q4 2025), and $17.3 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 19.80 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 24.06 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 15.00 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 16.29 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 8.62 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 6.96 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2.34 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 11.49 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.29 Bn
Dec 31, 2025 16.40 Bn
Sep 30, 2025 17.28 Bn
Jun 30, 2025 15.81 Bn
Mar 31, 2025 15.53 Bn
Dec 31, 2024 15.62 Bn
Sep 30, 2024 16.66 Bn
Jun 30, 2024 16.11 Bn
Mar 31, 2024 15.78 Bn
Dec 31, 2023 14.63 Bn
Sep 30, 2023 15.96 Bn
Jun 30, 2023 15.04 Bn
Mar 31, 2023 14.49 Bn
Dec 31, 2022 13.83 Bn
Sep 30, 2022 14.96 Bn
Jun 30, 2022 14.59 Bn
Mar 31, 2022 15.90 Bn
Dec 31, 2021 13.52 Bn
Sep 30, 2021 13.15 Bn
Jun 30, 2021 11.40 Bn
Mar 31, 2021 10.63 Bn
Dec 31, 2020 10.95 Bn
Sep 30, 2020 10.93 Bn
Jun 30, 2020 9.35 Bn
Mar 31, 2020 12.06 Bn
Dec 31, 2019 4.15 Bn
Sep 30, 2019 12.40 Bn
Jun 30, 2019 11.76 Bn
Mar 31, 2019 10.82 Bn
Dec 31, 2018 11.00 Bn
Sep 30, 2018 10.79 Bn
Jun 30, 2018 10.47 Bn
Mar 31, 2018 10.04 Bn
Dec 31, 2017 10.43 Bn
Sep 30, 2017 10.33 Bn
Jun 30, 2017 9.93 Bn
Mar 31, 2017 9.43 Bn
Dec 31, 2016 10.12 Bn
Sep 30, 2016 10.54 Bn
Jun 30, 2016 9.84 Bn
Mar 31, 2016 9.31 Bn
Dec 31, 2015 10.22 Bn
Sep 30, 2015 10.07 Bn
Jun 30, 2015 9.79 Bn
Mar 31, 2015 9.43 Bn
Dec 31, 2014 10.48 Bn
Sep 30, 2014 10.56 Bn
Jun 30, 2014 10.93 Bn
Mar 31, 2014 10.26 Bn
Dec 31, 2013 11.32 Bn
Sep 30, 2013 11.03 Bn
Jun 30, 2013 11.01 Bn
Mar 31, 2013 10.67 Bn
Dec 31, 2012 11.74 Bn
Sep 30, 2012 11.49 Bn
Jun 30, 2012 12.31 Bn
Mar 31, 2012 11.73 Bn
Dec 31, 2011 12.29 Bn
Sep 30, 2011 12.02 Bn
Jun 30, 2011 12.15 Bn
Mar 31, 2011 11.58 Bn
Dec 31, 2010 12.09 Bn
Sep 30, 2010 11.13 Bn
Jun 30, 2010 11.35 Bn
Mar 31, 2010 11.42 Bn
Dec 31, 2009 10.09 Bn
Sep 30, 2009 6.05 Bn
Jun 30, 2009 5.90 Bn
Mar 31, 2009 5.39 Bn